GNE-207
Catalog No. A18844
GNE-207 is a novel, potent, and orally bioavailable inhibitor of the bromodomain of CBP. GNE-207 has excellent CBP potency (CBP IC50?=?1?nM, MYC EC50?=?18?nM), and it exhibits a good pharmacokinetic profile.
Catalog Num | A18844 |
---|---|
M. Wt | 510.6 |
Formula | C29H30N6O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 2158266-58-9 |
Synonyms | GNE207, GNE 207 |
SMILES | O=C(NC)C1=NC=C(C2=CC3=C(C=N2)C(C4=NN(C5CCOCC5)C6=C4CN(C(C)=O)CC6)=CC=C3)C=C1 |
GNE-207 is a novel, potent, and orally bioavailable inhibitor of the bromodomain of CBP. GNE-207 has excellent CBP potency (CBP IC50?=?1?nM, MYC EC50?=?18?nM), and it exhibits a good pharmacokinetic profile.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.58 mL | 97.92 mL | 195.85 mL |
0.5 mM | 3.92 mL | 19.58 mL | 39.17 mL |
1 mM | 1.96 mL | 9.79 mL | 19.58 mL |
5 mM | 0.39 mL | 1.96 mL | 3.92 mL |
*The above data is based on the productmolecular weight 510.6. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.